Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Genetic diversity: GSK and Novartis launch Project Africa GRADIENT to optimise treatment responses for malaria and tuberculosis in Africa

Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients. Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years. Researchers … Read the full press release

Sanofi gains full global rights to a promising antibody for inflammatory disorders with the acquisition of Kymab

(PRESS RELEASE) PARIS/ CAMBRIDGE, 11-Jan-2021 — /EuropaWire/ — French multinational pharmaceutical company Sanofi to acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics. The agreement includes an upfront payment … Read the full press release

QIAGEN appoints Dr. Toralf Haag as a member of the Supervisory Board and the Audit Committee

(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release

Lundbeck welcomes acceptance of Vyepti’s marketing authorization application by the European Medicines Agency for the prevention of migraine

(PRESS RELEASE) VALBY, Denmark, 22-Dec-2020 — /EuropaWire/ — Danish international pharmaceutical company, H. Lundbeck A/S (Lundbeck) announces that its marketing authorization application for Vyepti™ (eptinezumab-jjmr) has been accepted by the European Medicines Agency (EMA). The filing seeks approval to introduce … Read the full press release

Aimmune Therapeutics’ PALFORZIA the first-ever treatment option approved for peanut allergy in the EU

(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release

OHMX.bio and Fujirebio Europe to develop clinical in vitro diagnostics platform incorporating third generation sequencing technologies

IVD-seq project received 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) (PRESS RELEASE) GENT, 8-Dec-2020 — /EuropaWire/ — Fujirebio Europe announces that together with its partner OHMX.bio, a provider of cutting-edge “omics” solutions, have been awarded a 720K … Read the full press release

EIB signs €15.0 million financing deal with AB Science to support the development of masitinib as a treatment for COVID-19

Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release

Novozymes welcomes new Executive Vice President of People, Sustainability & Brand Morten Enggaard Rasmussen

(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release

Almirall’s open innovation platform AlmirallShare announces two new partnerships aimed at finding new ways for the treatment of skin cancer and atopic dermatitis

These collaborations are in response to the calls for innovation via AlmirallShare, the open innovation platform of Almirall and aim to identify new biosignatures and treatments for skin cancer and atopic dermatitis AlmirallShare is responsible for 50% of the private-public … Read the full press release

AstraZeneca’s Imfinzi (durvalumab) approved in the US for new four-week 1,500mg fixed-dosing option

(PRESS RELEASE) CAMBRIDGE, 20-Nov-2020 — /EuropaWire/ — AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food and Drug Administration (FDA) approval of its Imfinzi (durvalumab) for an additional dosing option, a 1,500mg fixed dose every four … Read the full press release

Novartis signs 10 year 78 MW renewable Virtual Power Purchase Agreement (VPPA) with Enel Green Power

The energy will be generated by the 179.9 MW TICO Wind Farm, located in the Spanish province of Zaragoza, Enel Green Power will be a “Green Enabler” for Novartis, supporting the company along its environmental sustainability journey (PRESS RELEASE) ROME, … Read the full press release

Henkel closes epiCS® Skin Model Technology acquisition from SkinInVitro GmbH

Attractive portfolio with strong and successful models of the human skin Global dissemination of regulatory approved alternative test methods Important step towards the worldwide use and distribution of alternative test methods (PRESS RELEASE) DÜSSELDORF, 3-Nov-2020 — /EuropaWire/ — Henkel (ETR: … Read the full press release

Zeta Group and Siemens to work together for digital transformation of pharmaceutical processes

Strategic partnership for digital transformation of pharmaceutical processes Operational usage of digital plant data New Smart Engineering Services (SES) New modules improve integration in the value chain (PRESS RELEASE) NUREMBERG/ LIEBOCH/ GRAZ, 3-Nov-2020 — /EuropaWire/ — Siemens and Zeta Gmbh … Read the full press release

Palette Life Sciences expands availability of online education and resources for paediatric urologists across Europe

Palette Life Sciences provides valuable information regarding vesicoureteral reflux (VUR) to paediatric urologists in France, Germany, Italy and Spain (PRESS RELEASE) SANTA BARBARA, CALIF. / STOCKHOLM, 27-Oct-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release

Aimmune Therapeutics now a Nestlé Health Science company

(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq: AIMT). The company which specializes in developing and bringing new treatments to people with potentially life-threatening food allergies joins Nestlé … Read the full press release

Wet Macular Degeneration: Promising data for Novartis’ Beovu unveiled at EURETINA

In a post-hoc analysis of HAWK and HARRIER, fewer Beovu (brolucizumab) patients had early persistent fluid (12.5% vs. 20.4% of aflibercept patients), defined as the presence of intra-retinal fluid and/or sub-retinal fluid through week 12 of treatment1 Patients with early persistent fluid treated with Beovu experienced greater … Read the full press release

Eveliqure announces the initiation of a Phase 1 clinical study of its combined Shigella and ETEC vaccine candidate

(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release

The COVID-19 vaccine based on Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant system secures 300 million doses order from the European Commission (EC)

Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release

Roche unveils new Anti-SARS-CoV-2 serology test to quantitatively measure antibodies in people exposed to SARS-CoV-2

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. The test  targets antibodies against the spike protein. This is the focus of vaccines in development … Read the full press release

ESMO Virtual Congress 2020: Libtayo positive pivotal data offer hope for the treatment of advanced basal cell carcinoma, a difficult-to-treat cancer

Libtayo is the first investigational medicine to show a clinical benefit in advanced basal cell carcinoma following treatment with a hedgehog inhibitor in a prospective trial 31% objective response rate seen in trial patients, and an estimated 85% of responses … Read the full press release

Dr. Jean-Christophe Rufin to succeed Xavier Darcos as President of Sanofi Espoir Corporate Foundation

(PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced it has appointed Dr. Jean-Christophe Rufin as President of the Sanofi Espoir Corporate Foundation, aimed at reducing inequalities in health … Read the full press release

Sanofi tender offer for Principia Biopharma outstanding shares, August 28 – September 25, 2020

(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share … Read the full press release

Immune-mediated diseases biopharmaceutical Principia Biopharma Inc. acquired by Sanofi for approximately EUR 3.1 billion ($3.68 billion)

Further strengthens core R&D areas of autoimmune and allergic diseases Provides full control of brain-penetrant BTK inhibitor SAR442168 in multiple sclerosis (MS), making commercialization more efficient and eliminating future royalty payments Allows expansion of SAR442168 development program into other central … Read the full press release

New EU / AstraZeneca deal to help EU member states access the AZD1222 COVID-19 vaccine at no profit during the pandemic

(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release

Palette Life Sciences AB and Gedeon Richter Plc. Receive National Marketing Authorization in the United Kingdom for Novel Pain Relief Product, LIDBREE™

(PRESS RELEASE) SANTA BARBARA, CALIF., U.S.A. / BUDAPEST / STOCKHOLM, 5-Aug-2020 — /EuropaWire/ — Palette Life Sciences AB (‘Palette’) with Gedeon Richter Plc. (‘Richter’), today announced that as a part of a decentralised regulatory procedure including thirty European Union Economic … Read the full press release

Palette Life Sciences launches Deflux.com/UK, an online resource for paediatric urologists, parents and caregivers in the United Kingdom

Deflux.com/UK features important information about VUR, including symptoms, causes, risk factors and treatment options, such as Deflux®

Deflux.com/UK provides valuable information regarding vesicoureteral reflux (VUR); connects parents and caregivers of children with VUR with paediatric urologists (PRESS RELEASE)SANTA BARBARA, CALIF., U.S.A. / STOCKHOLM SWEDEN, 4-Aug-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release

Siemens AG on Varian acquisition by Siemens Healthineers: a transformational step of this kind wouldn’t have been possible in Siemens AG’s old conglomerate structure

Transformational milestone in execution of Siemens’ Vision 2020+ strategy Siemens Healthineers intends to acquire 100 percent stake in U.S. healthcare company at a purchase price of around $16.4 billion Acquisition to create global leader in cancer research and therapeutics and … Read the full press release

DHL Global Forwarding recertified for IATA CEIV Pharma and gets IATA’s approval for its training program

DHL once again been recognized by IATA for offering the highest standards for life sciences and healthcare shipments on a global level Air freight market leader DHL best positioned for more complex transports with its quality assurance initiative IATA also … Read the full press release

Four-year results from EU RCT validate the long-term safety profile of Philips’ Stellarex low-dose Drug-Coated Balloon

(PRESS RELEASE) AMSTERDAM, 26-Jun-2020 — /EuropaWire/ — The global leader in health technology Royal Philips (NYSE: PHG, AEX: PHIA) has announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). New data from the EU RCT reconfirms … Read the full press release